Blaming the PFO in Patients With Cryptogenic Ischemic Stroke Blaming the PFO in Patients With Cryptogenic Ischemic Stroke
What are the pathological implications of patent foramen ovale in patients undergoing surgery with or without a prior stroke or TIA?European Heart Journal (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 6, 2019 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news
Guidelines Address PFO Closure for Secondary Stroke Prevention
TUESDAY, April 2, 2019 -- In a Society for Cardiovascular Angiography and Interventions expert consensus statement published online March 21 in Catheterization and Cardiovascular Interventions, recommendations are presented for patent foramen ovale... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 2, 2019 Category: Pharmaceuticals Source Type: news
#MayoClinicRadio podcast: 2/23/19
Listen: Mayo Clinic Radio 2/23/19 Structural heart disease is a problem with the tissues or valves of the heart. On the Mayo Clinic Radio podcast, Dr. Peter Pollak, director of Structural Heart Disease at Mayo Clinic's Florida campus, discusses?mitral valve disease and another structural heart disease problem, patent foramen ovale?--?a hole in the heart that [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - February 25, 2019 Category: Databases & Libraries Source Type: news
PFO Closure Plus Antiplatelet Tx Advised for Cryogenic Stroke
FRIDAY, July 27, 2018 -- For patients younger than 60 years who have had a cryptogenic ischemic stroke thought to be secondary to patent foramen ovale (PFO), who are open to all treatment options, PFO closure plus antiplatelet therapy is recommended... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 27, 2018 Category: Pharmaceuticals Source Type: news
The Evil of the Patent Foramen Ovale: The Tip of the Iceberg The Evil of the Patent Foramen Ovale: The Tip of the Iceberg
A patent foramen ovale can be the cause devastating thromboembolic events. Are we underestimating the frequency of PFO-mediated events--and under-treating PFOs?European Heart Journal (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 5, 2018 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news
Gore Takes on Abbott with New PFO Stroke Indication
W.L. Gore & Associates has received FDA approval to expand the indication of the Gore Cardioform Septal Occluder to reduce the risk of recurrent ischemic stroke in patients. The device treats patients through the closure of patent foramen ovale (PFO).
Cardioform’s previous indication was for the closure of atrial septal defects that are up to 17mm in size.
Gore’s Structural Heart Leader, Jake Goble said Cardioform has the potential to redefine stroke prevention. Goble began working for Gore in 2007. It was around that time the company began to explore the possibility of having the Cardioform focus on stroke prevent...
Source: MDDI - April 3, 2018 Category: Medical Devices Authors: Omar Ford Tags: Cardiovascular Source Type: news
Gore wins expanded indications for Cardioform septal occluder
W.L. Gore & Associates said today it won expanded FDA indications for its Cardioform septal occluder, now cleared for the closure of patent foramen ovale to reduce the risk of recurrent ischemic stroke in certain patients.
The expanded application was supported by results from the Reduce study, which the Newark, Del.-based company said showed that closure of PFOs could significantly prevent recurrent ischemic stroke regardless of PFO anatomy.
“With the FDA approval of the Gore Cardioform septal occluder for PFO closure, we can now provide physicians with one device that can be used for both ASDs and PFOs. The val...
Source: Mass Device - April 3, 2018 Category: Medical Devices Authors: Fink Densford Tags: Cardiovascular Food & Drug Administration (FDA) Regulatory/Compliance W.L. Gore & Associates Source Type: news
FDA Approves GORE(R) CARDIOFORM Septal Occluder for PFO Closure to Prevent Recurrent Ischemic Stroke
Gore REDUCE Clinical Study demonstrated 77 percent relative reduction in recurrent ischemic stroke when PFO closure was combined with antiplatelet therapy, compared to antiplatelet therapy alone
FLAGSTAFF, Ariz., April 3, 2018 -- (Healthcare Sales & Mar... Devices, Interventional, Cardiology, FDA W. L. Gore, patent foramen ovale, CARDIOFORM, Septal Occluder (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 3, 2018 Category: Pharmaceuticals Source Type: news
PFO Seen Before Noncardiac Surgery Ups Perioperative Stroke Risk PFO Seen Before Noncardiac Surgery Ups Perioperative Stroke Risk
The risk increase was even greater for patients with a preoperative patent foramen ovale who were at low compared with high perioperative stroke risk by non-PFO criteria in a large patient cohort.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 12, 2018 Category: Consumer Health News Tags: Cardiology News Source Type: news
'Hole in Heart' Defect May Raise Stroke Risk
This common type of birth defect -- known as patent foramen ovale (PFO) -- is a hole between the upper chambers of the heart that does not close after birth. (Source: WebMD Health)
Source: WebMD Health - February 6, 2018 Category: Consumer Health News Source Type: news
' Hole in Heart' Defect May Raise Stroke Risk After Surgery
TUESDAY, Feb. 6, 2018 -- People born with a hole in their heart face an increased risk for stroke after surgery, a new study finds.
This common type of birth defect -- known as patent foramen ovale (PFO) -- is a hole between the upper chambers of... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - February 6, 2018 Category: General Medicine Source Type: news
Percutaneous PFO Closure Tied to Lower Risk for Recurrent Stroke
Patent foramen ovale (PFO) closure is associated with reduced risk for recurrent stroke among patients with cryptogenic stroke, according to two meta-analyses in the... (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - January 9, 2018 Category: Primary Care Source Type: news
Mixed migraine results for PFO closure study
Percutaneous closure of patent foramen ovale did not significantly lessen the frequency of migraines in patients with episodic migraines, according to a study published yesterday in the Journal of the American College of Cardiology.
Although the Premium trial missed its primary endpoint, the study met the secondary endpoint of reducing migraine days after PFO closure.
A sub-group analysis also found that patients with frequent aura experienced a significant reduction in migraine attacks with PFO closure. One of the trial’s investigators told Medscape that there is validity to right-to-left shunt closure, as long ...
Source: Mass Device - December 7, 2017 Category: Medical Devices Authors: Sarah Faulkner Tags: Clinical Trials Neurological Wall Street Beat stjudemedical Source Type: news
PFO Closure Reduces Strokes, and PPIs Increase Dementia Risk? PFO Closure Reduces Strokes, and PPIs Increase Dementia Risk?
New research suggests that reducing patent foramen ovale size could lessen stroke risk, while other work explores the role that PPIs might play in causing dementia.Medscape Neurology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 17, 2017 Category: Consumer Health News Tags: Neurology & Neurosurgery Commentary Source Type: news
Data Boosts Support for Abbott, Gore PFO Closure Tech
Devices designed to lower a patient's stroke risk by surgically closing a hole in the heart known as a patent foramen ovale, have historically had a tough time in clinical trials. Data from three separate studies published in the New England Journal of Medicine could go a long way toward boosting support two market-leading PFO closure devices, but figuring out who should have the procedure and who should not continues to be a gray area for clinicians and patients.
Long-term results from the RESPECT trial, which evaluated the Amplatzer device that Abbott acquired when it bought St. Jude Medical, along with new data from G...
Source: MDDI - September 15, 2017 Category: Medical Devices Authors: Amanda Pedersen Tags: MD & M Minneapolis R Medical Device Business Source Type: news
